Hanson & Doremus Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.95M | Sell |
10,917
-268
| -2% | -$91.7K | 0.4% | 37 |
|
|
2026
Q1 | $3.94M | Buy |
11,185
+138
| +1% | +$49.2K | 0.45% | 37 |
|
|
2025
Q4 | $3.62M | Sell |
11,047
-310
| -3% | -$98.3K | 0.43% | 37 |
|
|
2025
Q3 | $3.21M | Buy |
11,357
+10
| +0.1% | +$2.9K | 0.4% | 41 |
|
|
2025
Q2 | $3.17M | Buy |
11,347
+1,422
| +14% | +$403K | 0.42% | 44 |
|
|
2025
Q1 | $3.09M | Buy |
9,925
+8,405
| +553% | +$2.48M | 0.45% | 44 |
|
|
2024
Q4 | $396K | Hold |
1,520
| – | – | 0.06% | 124 |
|
|
2024
Q3 | $490K | Sell |
1,520
-72
| -5% | -$23.6K | 0.08% | 109 |
|
|
2024
Q2 | $497K | Buy |
1,592
+55
| +4% | +$16.2K | 0.08% | 111 |
|
|
2024
Q1 | $437K | Buy |
1,537
+98
| +7% | +$28.7K | 0.08% | 120 |
|
|
2023
Q4 | $414K | Hold |
1,439
| – | – | 0.08% | 123 |
|
|
2023
Q3 | $387K | Hold |
1,439
| – | – | 0.08% | 124 |
|
|
2023
Q2 | $319K | Hold |
1,439
| – | – | 0.07% | 138 |
|
|
2023
Q1 | $348K | Sell |
1,439
-348
| -19% | -$85.4K | 0.08% | 133 |
|
|
2022
Q4 | $469K | Buy |
1,787
+348
| +24% | +$93.3K | 0.1% | 124 |
|
|
2022
Q3 | $324K | Hold |
1,439
| – | – | 0.08% | 133 |
|
|
2022
Q2 | $350K | Hold |
1,439
| – | – | 0.09% | 133 |
|
|
2022
Q1 | $348K | Buy |
1,439
+590
| +69% | +$136K | 0.07% | 144 |
|
|
2021
Q4 | $191K | Hold |
849
| – | – | 0.04% | 188 |
|
|
2021
Q3 | $181K | Sell |
849
-20
| -2% | -$4.6K | 0.04% | 181 |
|
|
2021
Q2 | $221K | Sell |
869
-96
| -10% | -$23.6K | 0.07% | 152 |
|
|
2021
Q1 | $240K | Buy |
965
+16
| +2% | +$3.82K | 0.06% | 167 |
|
|
2020
Q4 | $218K | Buy |
949
+80
| +9% | +$18.4K | 0.05% | 167 |
|
|
2020
Q3 | $221K | Hold |
869
| – | – | 0.07% | 152 |
|
|
2020
Q2 | $205K | Sell |
869
-80
| -8% | -$18.3K | 0.06% | 153 |
|
|
2020
Q1 | $192K | Buy |
949
+17
| +2% | +$3.71K | 0.07% | 155 |
|
|
2019
Q4 | $225K | Sell |
932
-84
| -8% | -$18.5K | 0.06% | 159 |
|
|
2019
Q3 | $197K | Sell |
1,016
-89
| -8% | -$17.1K | 0.06% | 169 |
|
|
2019
Q2 | $204K | Hold |
1,105
| – | – | 0.06% | 172 |
|
|
2019
Q1 | $210K | Buy |
1,105
+45
| +4% | +$8.59K | 0.07% | 162 |
|
|
2018
Q4 | $206K | Hold |
1,060
| – | – | 0.07% | 157 |
|
|
2018
Q3 | $220K | Sell |
1,060
-97
| -8% | -$19.1K | 0.07% | 169 |
|
|
2018
Q2 | $214K | Sell |
1,157
-114
| -9% | -$20.2K | 0.07% | 169 |
|
|
2018
Q1 | $217K | Buy |
1,271
+80
| +7% | +$14.7K | 0.07% | 181 |
|
|
2017
Q4 | $207K | Hold |
1,191
| – | – | 0.07% | 176 |
|
|
2017
Q3 | $222K | Hold |
1,191
| – | – | 0.08% | 168 |
|
|
2017
Q2 | $205K | Hold |
1,191
| – | – | 0.08% | 167 |
|
|
2017
Q1 | $195K | Hold |
1,191
| – | – | 0.08% | 167 |
|
|
2016
Q4 | $174K | Hold |
1,191
| – | – | 0.08% | 170 |
|
|
2016
Q3 | $199K | Hold |
1,191
| – | – | 0.09% | 157 |
|
|
2016
Q2 | $181K | Buy |
1,191
+35
| +3% | +$5.44K | 0.08% | 162 |
|
|
2016
Q1 | $173K | Sell |
1,156
-45
| -4% | -$6.69K | 0.08% | 164 |
|
|
2015
Q4 | $195K | Buy |
1,201
+300
| +33% | +$47.2K | 0.09% | 163 |
|
|
2015
Q3 | $125K | Sell |
901
-20
| -2% | -$3.15K | 0.06% | 190 |
|
|
2015
Q2 | $141K | Hold |
921
| – | – | 0.06% | 189 |
|
|
2015
Q1 | $147K | Sell |
921
-35
| -4% | -$5.51K | 0.06% | 188 |
|
|
2014
Q4 | $152K | Hold |
956
| – | – | 0.07% | 185 |
|
|
2014
Q3 | $134K | Hold |
956
| – | – | 0.06% | 191 |
|
|
2014
Q2 | $113K | Sell |
956
-50
| -5% | -$5.79K | 0.05% | 204 |
|
|
2014
Q1 | $124K | Sell |
1,006
-85
| -8% | -$10.3K | 0.06% | 194 |
|
|
2013
Q4 | $124K | Sell |
1,091
-100
| -8% | -$11.4K | 0.06% | 185 |
|
|
2013
Q3 | $133K | Hold |
1,191
| – | – | 0.07% | 175 |
|
|
2013
Q2 | $118K | Buy |
+1,191
| New | +$124K | 0.06% | 174 |
|
Other funds holding AMGN
Hanson & Doremus Investment Management's AMGN Position: Q2 2026 in Review
Hanson & Doremus Investment Management reduced its Amgen (AMGN) stake by 2.4% in Q2 2026, selling an estimated $91.7K and leaving 10,917 shares worth $3.95M. The position accounts for 0.4% of the portfolio, ranked #37.
Hanson & Doremus Investment Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Hanson & Doremus Investment Management held 10,917 shares of Amgen worth $3.95M as of Q2 2026.
- Hanson & Doremus Investment Management sold 268 Amgen shares in Q2 2026, an estimated $91.7K.
- Amgen made up 0.4% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #37 holding.
- Hanson & Doremus Investment Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.